Revvity 8-K Signals Potential Leadership/Comp Changes

Ticker: RVTY · Form: 8-K · Filed: Jan 26, 2024 · CIK: 31791

Complexity: simple

Sentiment: neutral

Topics: executive-changes, compensation, corporate-governance

TL;DR

**Revvity filed an 8-K about potential executive changes, keep an eye out for details.**

AI Summary

Revvity, Inc. filed an 8-K on January 26, 2024, reporting an event that occurred on January 25, 2024, related to the departure or election of directors or officers and their compensatory arrangements. This filing indicates potential changes in leadership or executive compensation, which could impact the company's strategic direction and financial performance. Investors should pay attention to subsequent disclosures for specific details on these changes, as they can influence stock valuation and future growth prospects.

Why It Matters

Changes in executive leadership or compensation can significantly alter a company's strategy and financial health, directly affecting shareholder value.

Risk Assessment

Risk Level: medium — The filing indicates potential changes in leadership or compensation, which introduces uncertainty about future company direction and stability.

Analyst Insight

A smart investor would monitor Revvity's subsequent filings and news releases for specific details regarding the executive changes and compensation arrangements, as these will provide clarity on the company's future direction and potential impact on stock performance.

Key Numbers

Key Players & Entities

Forward-Looking Statements

FAQ

What specific event did Revvity, Inc. report in this 8-K filing?

Revvity, Inc. reported an event under Item 5.02, titled 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers,' which occurred on January 25, 2024.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing occurred on January 25, 2024.

What is the business address of Revvity, Inc. as stated in the filing?

The business address of Revvity, Inc. is 940 Winter Street, Waltham, Massachusetts 02451.

What is Revvity, Inc.'s Commission File Number?

Revvity, Inc.'s Commission File Number is 001-05075.

Under which section of the Securities Exchange Act of 1934 was this report filed?

This report was filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

Filing Stats: 647 words · 3 min read · ~2 pages · Grade level 10.6 · Accepted 2024-01-26 08:00:33

Key Financial Figures

Filing Documents

From the Filing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 25, 2024 Revvity, Inc. (Exact Name of Registrant as Specified in its Charter) Massachusetts 001-05075 04-2052042 (State or Other Jurisdiction of Incorporation or Organization) (Commission File Number) (IRS Employer Identification No.) 940 Winter Street , Waltham , Massachusetts 02451 (Address of Principal Executive Offices) (Zip Code) Registrant's telephone number, including area code: ( 781 ) 663-6900 Not applicable (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of exchange on which registered Common stock, $1 par value per share RVTY The New York Stock Exchange 1.875% Notes due 2026 RVTY 26 The New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On January 25, 2024, Dr. Sylvie Grgoire, a member of the Board of Directors (the "Board") of Revvity, Inc. ("Revvity" or the "Company") notified the Company of her decision not to stand for re-election to the Board at the annual meeting of shareholders of the Company scheduled to occur on April 23, 2024. Dr. Grgoire's decision not to stand for re-election is not due to any disagreement between Dr. Grgoire and the Company relating to the Company's operations, policies or practices. On January 25, 2024, the Board elected Michael A. Klobuchar and Sophie V. Vandebroek to serve on the Board, effective February 1, 2024. Neither Mr. Klobuchar nor Ms. Vandebroek will serve on a committee of the Board upon their election to the Board. In connection with their election to the Board, each of Mr. Klobuchar and Ms. Vandebroek will receive a stock award of Revvity common stock with a fair market value of $22,500 and a grant of restricted stock units with a fair market value of $27,500, representing the annual equity compensation payable to the Company's non-employee directors under the Company's non-employee director compensation program, prorated to reflect the remaining portion of the Board service year. Each award will be made on the customary terms and conditions of grants to Revvity's non-employee directors. In addition, each of Mr. Klobuchar and Ms. Vandebroek will be eligible to be paid the Company's annual cash retainer for non-employee directors of $90,000, also prorated to reflect the remaining portion of the Board service year. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. REVVITY, INC. Date: January 26, 2024 By: /s/ Joel S. Goldberg Joel S. Goldberg Senior Vice President, Administration, General Counsel and Secretary

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing